esketamine has been researched along with Astrocytosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, JZ; Lv, JM; Miao, HT; Shan, YD; Song, RX; Wang, LY; Wu, ZY; Zhang, DX; Zhang, LM; Zhang, W | 1 |
1 other study(ies) available for esketamine and Astrocytosis
| Article | Year |
|---|---|
Subanesthetic dose of S-ketamine improved cognitive dysfunction via the inhibition of hippocampal astrocytosis in a mouse model of post-stroke chronic stress.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Gliosis; Hippocampus; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Stroke | 2023 |